Rezania Dorna, Sokol Lubomir, Cualing Hernani D
Hematopathology and Laboratory Medicine Program, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, USA.
Cancer Control. 2007 Apr;14(2):112-23. doi: 10.1177/107327480701400204.
The classification of cutaneous lymphomas has been contentious. Two major competing classifications were the World Health Organization (WHO) and the European Organization for Research and Treatment of Cancer (EORTC). The principal authors met for a consensus meeting resulted in a combined classification called WHO-EORTC Classification of Cutaneous Lymphoma.
We review the classification of "mature" or peripheral T-cell lymphoma (PTCL) with high predilection to the skin as published by the WHO-EORTC. We also highlight new information and changes from the previous classifications of cutaneous PTCL according to the WHO classification or the EORTC classification. Finally, the salient findings are compared with similar-looking nodal PTCLs with a high frequency of skin involvement.
This review focuses on a rare group of cutaneous PTCLs other than mycosis fungoides or its variants. Changes from the previous classifications are discussed, and the rare group of nodal PTCLs with high predilection to the skin are presented. The salient findings, diagnostic features, and treatments are included, along with summary tables and clinical-histopathologic images.
This review may serve as a guide for hematologists, oncologists and dermatologists in the diagnosis and management of these rare, aggressive, and often difficult to diagnose lymphomas. Although cutaneous lymphomas are morphologically identical to systemic lymphomas, the former behave differently, require divergent management, and should be recognized as separate entities. The consensus WHO-EORTC classification presents unified terminology and definitions to promote conformity in diagnosing and treating these cases, to foster a multidisciplinary approach to these often-obscure diseases, and to lead to more advances in identifying molecular targets specific to these entities.
皮肤淋巴瘤的分类一直存在争议。两种主要的竞争分类是世界卫生组织(WHO)分类和欧洲癌症研究与治疗组织(EORTC)分类。主要作者召开了一次共识会议,产生了一种名为WHO-EORTC皮肤淋巴瘤分类的联合分类。
我们回顾了WHO-EORTC发布的对皮肤有高度偏好的“成熟”或外周T细胞淋巴瘤(PTCL)的分类。我们还强调了根据WHO分类或EORTC分类,与之前皮肤PTCL分类相比的新信息和变化。最后,将显著发现与皮肤受累频率高的外观相似的结内PTCL进行比较。
本综述聚焦于除蕈样肉芽肿或其变异型之外的一组罕见皮肤PTCL。讨论了与之前分类的变化,并介绍了对皮肤有高度偏好的罕见结内PTCL组。包括显著发现、诊断特征和治疗方法,以及汇总表和临床组织病理学图像。
本综述可为血液科医生、肿瘤内科医生和皮肤科医生诊断和管理这些罕见、侵袭性且通常难以诊断的淋巴瘤提供指导。尽管皮肤淋巴瘤在形态上与系统性淋巴瘤相同,但前者行为不同,需要不同的管理方式,应被视为独立的实体。WHO-EORTC共识分类提供了统一的术语和定义,以促进这些病例诊断和治疗的一致性,促进对这些常隐匿疾病的多学科方法,并在识别这些实体特有的分子靶点方面取得更多进展。